Get the Stockscreener App
121.43
0.65%
-0.80
After Hours:
121.43
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $121.43, with a volume of 4.27M.
It is down -0.65% in the last 24 hours and down -4.70% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$122.23
Open:
$121.02
24h Volume:
4.27M
Relative Volume:
0.85
Market Cap:
$51.26B
Revenue:
$9.47B
Net Income/Loss:
$2.67B
P/E Ratio:
20.17
EPS:
6.0218
Net Cash Flow:
$2.28B
1W Performance:
-7.38%
1M Performance:
-4.70%
6M Performance:
-20.80%
1Y Performance:
-27.40%
1-Day Range:
$118.28
$121.87
1-Week Range:
$118.28
$130.05
52-Week Range:
$115.25
$177.00
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS vs TAK, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
121.43 | 51.60B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.88 | 56.11B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
HLN
Haleon Plc Adr
|
10.28 | 46.00B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.05 | 36.98B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
478.16 | 21.26B | 3.13B | 1.27B | 1.12B | 26.39 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-21-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-17-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jun-18-25 | Downgrade | Stifel | Buy → Hold |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
Zoetis Builds Future for Livestock Health - Farms.com
Zoetis to acquire genomics business - The Western Producer
Jensen Quality Growth Equity Decided to Sell Its Stake in Zoetis (ZTS) - Insider Monkey
Heron Bay Capital Management Has $6.33 Million Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Pitcairn Co. Has $2.54 Million Position in Zoetis Inc. $ZTS - MarketBeat
Zoetis: Good Potential To Re-Rate Higher Over 3 To 5 Years (undefined:ZTS) - Seeking Alpha
Zoetis to Participate in Upcoming Investor Conferences - The AI Journal
Injected Veterinary Pain Management Drugs Market Set to Witness - openPR.com
Zoetis Inc. $ZTS Stake Raised by Dimensional Fund Advisors LP - MarketBeat
Managed Asset Portfolios LLC Acquires Shares of 8,400 Zoetis Inc. $ZTS - MarketBeat
Zoetis Stock: Why 12 Pipeline Blockbusters Could Support a 40% Upside - TIKR.com
ZTS Earnings History & Surprises | EPS & Revenue Results | ZOETIS INC (NYSE:ZTS) - ChartMill
Quantbot Technologies LP Sells 12,136 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Lansing-based Neogen sells genomics business to Zoetis - Michigan Farm News
Zoetis to acquire Neogen animal genomics business for $160M - NJBIZ
Zoetis, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape - Markets Mojo
Neogen Food Safety Corporation Sells Genomics Business to Zoetis Animal Health - Pet Age
Zoetis to acquire animal genomics business from Neogen - Pet Food Processing
Hutchinson Capital Management CA Invests $11.51 Million in Zoetis Inc. $ZTS - MarketBeat
Zoetis to acquire Neogen’s animal genomics business for $160M - The National Provisioner
CI Investments Inc. Reduces Holdings in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Shares Acquired by Elo Mutual Pension Insurance Co - MarketBeat
Bahl & Gaynor Inc. Sells 189,941 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Holdings Decreased by 111 Capital - MarketBeat
Zoetis to acquire Neogen’s genomics unit for $160 million By Investing.com - Investing.com South Africa
How Do Investors Really Feel About Zoetis Inc? - Sahm
Zoetis Shares Slide 1.63% as Trading Volume Dives 45.86% to 339th on NYSE Amid $160M Genomics Acquisition - Bitget
Zoetis Inc. stock outperforms competitors despite losses on the day - MarketWatch
William Blair reiterates Zoetis stock rating after genomics deal - Investing.com
Zoetis to Acquire Neogen’s Animal Genomics Business - drovers.com
Zoetis to acquire Neogen’s genomics unit for $160 million - Investing.com Nigeria
Zoetis stock slips despite deal for Neogen genomics unit, BofA and Leerink React - Investing.com
Zoetis to acquire Neogen’s genomics business - Feedstuffs
Zoetis Genomics Deal Deepens Precision Animal Health Growth Story - Yahoo Finance
Waverton Investment Management Ltd Sells 15,037 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis to Acquire Neogen's Animal Genomics Business for $160 Million - marketscreener.com
Zoetis Inc. (ZTS) Stock Analysis: Exploring A 15% Upside In The Animal Health Sector - DirectorsTalk Interviews
Zoetis (ZTS) to Acquire Neogen's Animal Genomics Unit for $160M - GuruFocus
Neogen To Sell Genomics Business To Zoetis For $160 Mln - Nasdaq
Zoetis Shares Dip as Company Announces $160M Neogen Deal By Investing.com - Investing.com Canada
Zoetis Shares Dip as Company Announces $160M Neogen Deal - Investing.com
First Long Island Investors LLC Has $20.20 Million Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Fairtree Asset Management Pty Ltd Has $2.35 Million Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Neogen Announces Sale of Genomics Business to Zoetis - Business Wire
Fox Run Management L.L.C. Decreases Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Davis R M Inc. Sells 12,873 Shares of Zoetis Inc. $ZTS - MarketBeat
Zacks.com featured highlights include Ross Stores, Globe Life, Banco Bilbao, Zoetis and TE Connectivity - Yahoo Finance
Zoetis Inc. entered into a definitive agreement to acquire Genomics Business from Neogen Corporation from Neogen Corporation for $160 million. - marketscreener.com
Zoetis Inc. $ZTS Shares Sold by US Bancorp DE - MarketBeat
Huntington National Bank Sells 22,085 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.68%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):